About [email protected]

This author has not yet filled in any details.
So far [email protected] has created 21 blog entries.

Biogen And Eisai Say Alzheimer’s Drug A Success, Encouraging Phase II Results in Alzheimer’s Disease

2020-08-17T20:53:26+00:00Industry News|

A complicated new clinical trial could give some hope to Alzheimer’s patients and investors in drug companies. But there are [...]

CHMP Issues Positive Opinion To Expand Jardiance®, Synjardy® And Glyxambi® Labels To Include Positive Effects On Cardiovascular And Renal Outcomes

2020-08-17T20:55:47+00:00Industry News, Regulatory|

INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)–Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) [...]

Novo’s oral semaglutide bests Lilly and Boehringer Ingelheim’s Jardiance in phase 3, but questions remain

2020-08-17T20:58:07+00:00Industry News|

Even as Novo Nordisk works to steal diabetes market share with its new GLP-1 drug Ozempic, it’s advancing an oral [...]

Araim Pharmaceuticals’ Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

2020-08-17T21:05:02+00:00Biopharmaceutical Product Development, Industry News|

The double blind, randomized, placebo-controlled, two-center study published in Investigative Ophthalmology & Visual Science assessed the safety and efficacy of [...]

Chronic Severe Pain Defines Lives of Sarcoidosis Patients, According to Sarcoidosis/ FSR/ ARAIM Survey Results

2020-08-17T21:06:12+00:00Biopharmaceutical Product Development, Industry News|

A large proportion of sarcoidosis patients live with severe chronic pain despite the heavy use of painkillers, including opioids, a [...]

Go to Top